1. Home
  2. SURG vs HBIO Comparison

SURG vs HBIO Comparison

Compare SURG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.87

Market Cap

26.9M

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.60

Market Cap

22.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
HBIO
Founded
2006
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
22.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
SURG
HBIO
Price
$0.87
$0.60
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$9.75
$2.50
AVG Volume (30 Days)
450.6K
537.0K
Earning Date
03-24-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
$87,371,000.00
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
$7.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.28
52 Week High
$3.47
$1.43

Technical Indicators

Market Signals
Indicator
SURG
HBIO
Relative Strength Index (RSI) 23.52 54.16
Support Level $0.86 $0.53
Resistance Level $1.09 $0.65
Average True Range (ATR) 0.09 0.04
MACD -0.01 0.01
Stochastic Oscillator 1.75 69.66

Price Performance

Historical Comparison
SURG
HBIO

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: